3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Solid Tumors
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharangeal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lung Neoplasms
1
Kidney Neoplasms
1
Kidney Diseases
1
Hemangiosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
CRC
1
Interventions
Biopsy
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
6
duvelisib
5
Cyclophosphamide
5
ruxolitinib
4
Vincristine
4
10-propargyl-10-deazaaminopterin
4
pembrolizumab
3
X-Rays
3
Prednisone
3
Etoposide
3
Doxorubicin
3
tazemetostat
2
sodium-iodide symporter
2
cemiplimab
2
belinostat
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Cytarabine
2
Bortezomib
2
Azacitidine
2
venetoclax
1
talimogene laherparepvec
1
romidepsin
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
spartalizumab
×
90 days
×
Clear all
No trials found.